Alves, V.; Martins, P.H.; Miranda, B.; de Andrade, I.B.; Pereira, L.; Maeda, C.T.; de Sousa Araújo, G.R.; Frases, S.
Assessing the In Vitro Potential of Glatiramer Acetate (Copaxone®) as a Chemotherapeutic Candidate for the Treatment of Cryptococcus neoformans Infection. J. Fungi 2023, 9, 783.
https://doi.org/10.3390/jof9080783
AMA Style
Alves V, Martins PH, Miranda B, de Andrade IB, Pereira L, Maeda CT, de Sousa Araújo GR, Frases S.
Assessing the In Vitro Potential of Glatiramer Acetate (Copaxone®) as a Chemotherapeutic Candidate for the Treatment of Cryptococcus neoformans Infection. Journal of Fungi. 2023; 9(8):783.
https://doi.org/10.3390/jof9080783
Chicago/Turabian Style
Alves, Vinicius, Pedro Henrique Martins, Bruna Miranda, Iara Bastos de Andrade, Luiza Pereira, Christina Takiya Maeda, Glauber Ribeiro de Sousa Araújo, and Susana Frases.
2023. "Assessing the In Vitro Potential of Glatiramer Acetate (Copaxone®) as a Chemotherapeutic Candidate for the Treatment of Cryptococcus neoformans Infection" Journal of Fungi 9, no. 8: 783.
https://doi.org/10.3390/jof9080783
APA Style
Alves, V., Martins, P. H., Miranda, B., de Andrade, I. B., Pereira, L., Maeda, C. T., de Sousa Araújo, G. R., & Frases, S.
(2023). Assessing the In Vitro Potential of Glatiramer Acetate (Copaxone®) as a Chemotherapeutic Candidate for the Treatment of Cryptococcus neoformans Infection. Journal of Fungi, 9(8), 783.
https://doi.org/10.3390/jof9080783